Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ALHC✓SelectedUSD · ALHCGSK vs ALHC performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs ALHC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.2%
ALHC return
-58.1%
Excess return
+64.3%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioALHCExcessAlpha
1D-1.3%-11.8%+10.5%-0.9%
7D-3.1%-12.6%+9.5%-2.7%
30D-0.9%-20.0%+19.1%-0.2%
3M-4.2%-49.2%+45.0%-2.1%
6M-1.6%-58.7%+57.1%+0.1%
YTD+2.6%-66.0%+68.6%+2.3%
1Y+6.2%-58.3%+64.5%+3.3%
All+6.2%-58.1%+64.3%+3.3%

Cumulative growth

Daily Returns

Daily percentage return beside ALHC.

Daily Out/Under-Performance

Portfolio return minus ALHC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling